Cardiac Surgery During Pregnancy.
Cardiac surgery during pregnancy is rare — estimated at 1 to 2 per 100,000 pregnancies — but when it is needed, the stakes are extraordinarily high. The most common indications are acute aortic dissection, prosthetic valve thrombosis, refractory heart failure from valvular disease, and infective endocarditis that cannot be medically managed. The physiologic changes of pregnancy (increased blood volume by 40-50%, elevated heart rate, decreased systemic vascular resistance) can unmask or worsen pre-existing cardiac conditions, sometimes precipitating a crisis that demands surgical intervention. The central tension in cardiac surgery during pregnancy is the competing interests of maternal and fetal well-being. Cardiopulmonary bypass, which is standard for most cardiac operations, carries significant risks to the fetus: hypothermia, non-pulsatile flow, hemodilution, and potential uteroplacental insufficiency can lead to fetal distress, preterm labor, or fetal demise. Reported fetal mortality rates with cardiac surgery during pregnancy range from 10-30% in historical series, though contemporary outcomes have improved. Every decision in this scenario — timing, surgical approach, bypass strategy, temperature management — requires a multidisciplinary team including cardiac surgery, maternal-fetal medicine, anesthesiology, and neonatology.
What the evidence shows.
A systematic review of 161 cases of cardiac surgery during pregnancy (Barth et al., 2021) reported maternal mortality of 6% and fetal mortality of 16.7%. Outcomes were better in the second trimester compared to the first or third: organogenesis is complete (reducing teratogenic risk), and the uterus has not yet compressed the inferior vena cava significantly (reducing hemodynamic compromise during bypass). Normothermic or mildly hypothermic bypass (above 32 degrees Celsius), high-flow perfusion, and short bypass times were associated with better fetal outcomes. When surgery can be delayed to after 28 weeks of gestation, cesarean delivery immediately prior to cardiac surgery has been performed successfully, allowing independent management of the neonate.
Current recommendations.
Current expert consensus recommends: (1) exhaust all medical management options before considering surgery; (2) if surgery is unavoidable, the second trimester (weeks 13-28) is the optimal window; (3) use normothermic, high-flow cardiopulmonary bypass with pulsatile perfusion when possible; (4) continuous fetal monitoring during bypass; (5) after 28 weeks, consider cesarean delivery prior to cardiac surgery if both procedures are necessary; (6) multidisciplinary team planning is mandatory. These cases should be managed at centers with expertise in both complex cardiac surgery and high-risk obstetrics.
Why this matters for your decision.
The rarity of cardiac surgery during pregnancy means that even experienced cardiac surgeons may have limited personal experience with these cases. A second opinion from a Heart Team with expertise in this scenario can identify alternatives to surgery (percutaneous interventions, medical optimization) that the primary team may not have considered, or can confirm that surgery is truly necessary and help optimize the timing and approach to protect both mother and baby.
Need help with this decision?
Our Heart Team evaluates your specific situation with AI-augmented analysis and dual-physician review.